News
Please, enter cell line, author or any other phrase or word you would like to search for.
PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership
PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
BioStock: PHI charts a bold course to impact regenerative medicine
BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
BioStock: The five best life science stocks of the first half-year
PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
European Patent Office intends to grant PHI patent on synthetic antibodies
PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
BioStock: PHI’s CEO reflects on global roadshow success
BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.
Interim Report 4 2022/23
Sales continue to grow, and the year ended up with the highest turnover for a year in PHI, so far.
Notice that Interim Report 4 2022/23 will be published on June 26, 2023
PHI changes the date for publication of Interim Report 4 2022/23 to June 26, 2023.
PHI’s new HoloMonitor M4FL premiers at major scientific conferences
PHI introduces the HoloMonitor M4FL system to the global scientific community at two major scientific conferences this June.
PHI AB’s warrant exercise registered with the Swedish Companies Registration Office
PHI today announces that the new shares from the exercise of warrants of series TO 3 have been registered with the Swedish Companies Registration Office.
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)
Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on 9 May 2023. The following resolutions were passed at the meeting: